Related references
Note: Only part of the references are listed.Characterization of recombinant fructose-1,6-bisphosphatase gene mutations: evidence of inhibition/activation of FBPase protein by gene mutation
Gemma Topaz et al.
BIOSCIENCE REPORTS (2019)
In silico screening of a novel scaffold for fructose-1,6-bisphosatase (FBPase) inhibitors
Yunyuan Huang et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2019)
International practices in the dietary management of fructose 1-6 biphosphatase deficiency
A. Pinto et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase
Roger W. Hunter et al.
NATURE MEDICINE (2018)
Modulating Mobility: a Paradigm for Protein Engineering?
Margaret McAuley et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2017)
Fructose-1,6-bisphosphatase inhibitors: A new valid approach for management of type 2 diabetes mellitus
Ramandeep Kaur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Fructose-1,6-bisphosphatase-1 decrease may promote carcinogenesis and chemoresistance in cervical cancer
Haoran Li et al.
MOLECULAR MEDICINE REPORTS (2017)
Allostery in enzyme catalysis
George P. Lisi et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2017)
Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
Hidenari Hirata et al.
CANCER RESEARCH (2016)
T-to-R switch of muscle fructose-1,6-bisphosphatase involves fundamental changes of secondary and quaternary structure
Jakub Barciszewski et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2016)
Fructose 1,6-bisphosphatase deficiency: clinical, biochemical and genetic features in French patients
Elise Lebigot et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2015)
Synthesis and structure-activity relationship of non-phosphorus-based fructose-1,6-bisphosphatase inhibitors: 2,5-Diphenyl-1,3,4-oxadiazoles
Ben-Ren Liao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Fructose-1,6-bisphosphatase opposes renal carcinoma progression
Bo Li et al.
NATURE (2014)
Mechanism of Displacement of a Catalytically Essential Loop from the Active Site of Mammalian Fructose-1,6-bisphosphatase
Yang Gao et al.
BIOCHEMISTRY (2013)
Decreased fructose-1,6-bisphosphatase-2 expression promotes glycolysis and growth in gastric cancer cells
He Li et al.
MOLECULAR CANCER (2013)
In Silico Identification of Structure Requirement for Novel Thiazole and Oxazole Derivatives as Potent Fructose 1,6-Bisphosphatase Inhibitors
Ming Hao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Discovery of a Series of Phosphonic Acid-Containing Thiazoles and Orally Bioavailable Diamide Prodrugs That Lower Glucose in Diabetic Animals Through Inhibition of Fructose-1,6-Bisphosphatase
Qun Dang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Rational Design, Synthesis, and Potency of N-Substituted Indoles, Pyrroles, and Triarylpyrazoles as Potential Fructose 1,6-Bisphosphatase Inhibitors
Aleksandra Rudnitskaya et al.
CHEMMEDCHEM (2010)
Structure and Activity of the Metal-independent Fructose-1,6-bisphosphatase YK23 from Saccharomyces cerevisiae
Ekaterina Kuznetsova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Fructose-1,6-bisphosphatase Inhibitors. 2. Design, Synthesis, and Structure-Activity Relationship of a Series of Phosphonic Acid Containing Benzimidazoles that Function as 5′-Adenosinemonophosphate (AMP) Mimics
Qun Dang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Fructose-1,6-bisphosphatase Inhibitors. 1. Purine Phosphonic Acids as Novel AMP Mimics
Qun Dang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats
Taishi Yoshida et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Allosteric regulation and catalysis emerge via a common route
Nina M. Goodey et al.
NATURE CHEMICAL BIOLOGY (2008)
Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes
Qun Dang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity
Mark D. Erion et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Structures of mammalian and bacterial fructose-1,6-bisphosphatase reveal the basis for synergism in AMP/fructose 2,6-bisphosphate inhibition
Justin K. Hines et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Structure of inhibited fructose-1,6-bisphosphatase from Escherichia coli -: Distinct allosteric inhibition sites for AMP and glucose 6-phosphate and the characterization of a gluconeogenic switch
Justin K. Hines et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats
Paul D. van Poelje et al.
DIABETES (2006)
MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes
MD Erion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The C1-C2 interface residue lysine 50 of pig kidney fructose-1,6-bisphosphatase has a crucial role in the cooperative signal transmission of the AMP inhibition
JG Cárcamo et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
